The cell surface marker CD15 (also known as stage-specific embryonic antigen, SSEA1) has been proposed as a general marker for brain tumour stem cells in both gliomas and medulloblastomas (Son et al., 2009; Ward et al., 2009). This evidence concerns the gene FUT4 and glioma.